Format

Send to

Choose Destination
Leuk Res. 2009 Oct;33(10):1313-8. doi: 10.1016/j.leukres.2009.02.010. Epub 2009 Mar 17.

Estimating the prevalence of myelodysplastic syndromes in patients with unexplained cytopenias: a retrospective study of 322 bone marrows.

Author information

1
MDS Research Program, Department of Hematology/Oncology, Odette Cancer Center, Sunnybrook Health Sciences Center, Toronto, Ontario, Canada. rena.buckstein@sunnybrook.ca

Abstract

Although unexplained anemia is common in the elderly, the prevalence of MDS is poorly defined. We reviewed 2267 bone marrows reviewed at our center between the years 2002 and 2005. Of these, 322 met our criteria for inclusion (14%). Seventy-three patients (22.6%) had a confirmed diagnosis of MDS and 32 (9.9%) had suspected MDS. Confirmed or suspected MDS was more likely in patients aged >65 (31.5% and 11%, respectively). Age, MCV, LDH and RDW were independently predictive of MDS. Extrapolation of our findings to the elderly anemic individuals in the community suggests MDS prevalence may be higher than previously postulated.

PMID:
19282029
DOI:
10.1016/j.leukres.2009.02.010
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center